Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Mandelikova
Cost-Effectiveness Analysis of Bendamustin-Rituximab Compared to Chop-Rituximab in the Treatment of Indolent Follicular Non-Hodgkin Lymhoma in the Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Rituximab in the Treatment of B-Cell Non-Hodgkin Lymphoma, Focus on Outcomes and Comparative Effectiveness
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Cost-Effectiveness Analysis of Atorvastatin Compared to Simvastatin in the Prevention of Cardiovascular Diseases in the Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Gene Polymorphisms as Predictors of Treatment Efficacy and Toxicity in Patients With Indolent Non-Hodgkin Lymphomas Receiving Bendamustine and Rituximab
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Characteristics and Management of Rash Following Lenalidomide and Rituximab in Patients With Untreated Indolent Non-Hodgkin Lymphoma
Haematologica
Hematology
Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Differences in Quality of Life Between Bendamustine-Rituximab and R-Chop/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Pin68 - Cost-Effectiveness Analysis of Isavuconazole for the Treatment of Invasive Aspergillosis in the Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Indolenter Lymphome: Bendamustin Plus Rituximab in Der Firstline
Info Onkologie
